Director/PDMR Shareholding
February 03 2010 - 7:44AM
UK Regulatory
TIDMNVOB
Trading in Novo Nordisk shares by board members, executives and associated
persons as reported to Novo Nordisk on 2 February 2010
In accordance with Section 28a of the Danish Securities Trading Act, Novo
Nordisk is required on a daily basis to publish trading in Novo Nordisk shares
by the company's board members, executives and their associated persons as
reported by those persons to Novo Nordisk.
As from 2004, members of Novo Nordisk's Executive Management and other members
of the Senior Management Board have participated in a long-term share-based
incentive programme where a proportion of the calculated shareholder value
creation has been allocated to a joint pool for the participants. For
2006, 261,500 shares were allocated to the joint pool and the market value of
the scheme was expensed in the accounts for 2006. In accordance with the
principles of the programme, the Board of Directors of Novo Nordisk A/S on 1
February 2010 evaluated that the conditions for release of the joint pool of
shares have been fulfilled. Accordingly, the shares in the joint pool were
transferred to 24 current and former members of senior management on 2 February
2010.
Further, members of Executive Management have traded shares through the exercise
of options.
Please find below a statement of such trading in shares issued by Novo Nordisk.
+--------------------------------+---------------------------------------------+
|Name |Pecun Inc. |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Associated to a member of the Board of |
| |Directors (Hannu Ryöppönen) |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Purchase of shares |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |1,000 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |DKK 370,468 |
+--------------------------------+---------------------------------------------+
+--------------------------------+---------------------------------------------+
|Name |Lars Rebien Sørensen |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Chief Executive Officer |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Other transaction (transfer of shares in |
| |accordance with long-term incentive |
| |programme) |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |26,138 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |0 (transferred in accordance with the |
| |long-term incentive programme for 2006) |
+--------------------------------+---------------------------------------------+
+--------------------------------+--------------------------+
|Name |Lars Rebien Sørensen |
+--------------------------------+--------------------------+
|Reason for reporting |Chief Executive Officer |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |26,138 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 9,627,410 |
+--------------------------------+--------------------------+
+--------------------------------+----------------------------------------+
|Name |Lars Rebien Sørensen |
+--------------------------------+----------------------------------------+
|Reason for reporting |Chief Executive Officer |
+--------------------------------+----------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+----------------------------------------+
|Type of transaction |Exercise of options (purchase of shares)|
+--------------------------------+----------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+----------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+----------------------------------------+
|Volume of transaction |29,000 shares |
+--------------------------------+----------------------------------------+
|Total value of transaction |DKK 4,814,000 |
+--------------------------------+----------------------------------------+
+--------------------------------+--------------------------+
|Name |Lars Rebien Sørensen |
+--------------------------------+--------------------------+
|Reason for reporting |Chief Executive Officer |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |29,000 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 10,681,570 |
+--------------------------------+--------------------------+
+--------------------------------+---------------------------------------------+
|Name |Jesper Brandgaard |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Chief Financial Officer |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Other transaction (transfer of shares in |
| |accordance with long-term incentive |
| |programme) |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |0 (transferred in accordance with the |
| |long-term incentive programme for 2006) |
+--------------------------------+---------------------------------------------+
+--------------------------------+--------------------------+
|Name |Jesper Brandgaard |
+--------------------------------+--------------------------+
|Reason for reporting |Chief Financial Officer |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 6,420,166 |
+--------------------------------+--------------------------+
+--------------------------------+----------------------------------------+
|Name |Jesper Brandgaard |
+--------------------------------+----------------------------------------+
|Reason for reporting |Chief Financial Officer |
+--------------------------------+----------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+----------------------------------------+
|Type of transaction |Exercise of options (purchase of shares)|
+--------------------------------+----------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+----------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+----------------------------------------+
|Volume of transaction |14,500 shares |
+--------------------------------+----------------------------------------+
|Total value of transaction |DKK 2,407,000 |
+--------------------------------+----------------------------------------+
+--------------------------------+--------------------------+
|Name |Jesper Brandgaard |
+--------------------------------+--------------------------+
|Reason for reporting |Chief Financial Officer |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |10,000 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 3,683,400 |
+--------------------------------+--------------------------+
+--------------------------------+---------------------------------------------+
|Name |Lise Kingo |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Chief of Staffs |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Other transaction (transfer of shares in |
| |accordance with long-term incentive |
| |programme) |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |0 (transferred in accordance with the |
| |long-term incentive programme for 2006) |
+--------------------------------+---------------------------------------------+
+--------------------------------+--------------------------+
|Name |Lise Kingo |
+--------------------------------+--------------------------+
|Reason for reporting |Chief of Staffs |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 6,420,166 |
+--------------------------------+--------------------------+
+--------------------------------+----------------------------------------+
|Name |Lise Kingo |
+--------------------------------+----------------------------------------+
|Reason for reporting |Chief of Staffs |
+--------------------------------+----------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+----------------------------------------+
|Type of transaction |Exercise of options (purchase of shares)|
+--------------------------------+----------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+----------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+----------------------------------------+
|Volume of transaction |19,000 |
+--------------------------------+----------------------------------------+
|Total value of transaction |DKK 1,852,500 |
+--------------------------------+----------------------------------------+
+--------------------------------+--------------------------+
|Name |Lise Kingo |
+--------------------------------+--------------------------+
|Reason for reporting |Chief of Staffs |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |19,000 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 6,998,460 |
+--------------------------------+--------------------------+
+--------------------------------+---------------------------------------------+
|Name |KÃ¥re Schultz |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Chief Operating Officer |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Other transaction (transfer of shares in |
| |accordance with long-term incentive |
| |programme) |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |0 (transferred in accordance with the |
| |long-term incentive programme for 2006) |
+--------------------------------+---------------------------------------------+
+--------------------------------+---------------------------------------------+
|Name |Mads Krogsgaard Thomsen |
+--------------------------------+---------------------------------------------+
|Reason for reporting |Chief Science Officer |
+--------------------------------+---------------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+---------------------------------------------+
|Type of transaction |Other transaction (transfer of shares in |
| |accordance with long-term incentive |
| |programme) |
+--------------------------------+---------------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+---------------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+---------------------------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+---------------------------------------------+
|Total value of transaction |0 (transferred in accordance with the |
| |long-term incentive programme for 2006) |
+--------------------------------+---------------------------------------------+
+--------------------------------+--------------------------+
|Name |Mads Krogsgaard Thomsen |
+--------------------------------+--------------------------+
|Reason for reporting |Chief Science Officer |
+--------------------------------+--------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261|
+--------------------------------+--------------------------+
|Type of transaction |Sale of shares |
+--------------------------------+--------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+--------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+--------------------------+
|Volume of transaction |17,430 shares |
+--------------------------------+--------------------------+
|Total value of transaction |DKK 6,420,166 |
+--------------------------------+--------------------------+
+--------------------------------+----------------------------------------+
|Name |Mads Krogsgaard Thomsen |
+--------------------------------+----------------------------------------+
|Reason for reporting |Chief Science Officer |
+--------------------------------+----------------------------------------+
|Financial instrument and ID code|Novo Nordisk B DK006010261 |
+--------------------------------+----------------------------------------+
|Type of transaction |Exercise of options (purchase of shares)|
+--------------------------------+----------------------------------------+
|Date of transaction |2 February 2010 |
+--------------------------------+----------------------------------------+
|Place of transaction |NASDAQ OMX Copenhagen |
+--------------------------------+----------------------------------------+
|Volume of transaction |14,500 shares |
+--------------------------------+----------------------------------------+
|Total value of transaction |DKK 2,407,000 |
+--------------------------------+----------------------------------------+
Definitions and background information:
Publication
Publication shall take place the day after Novo Nordisk receives sufficient
information on the trading. Publication is only required when the total amount
of transactions of a specific board member/executive and his/her associated
persons in any one calendar year has reached 5,000 euros.
Board members and executives are members of the Board of Directors and Executive
Management, respectively, of Novo Nordisk A/S. Associated persons are defined as
the following persons associated to a board member/executive: 1) spouse or
cohabitant, 2) children under the age of 18 years, 3) relatives defined as
brothers, sisters, parents, grandparents etc, children, grandchildren etc who
have shared the same household with a board member/executive for at least one
year, and 4) any legal person, including a company, a foundation or a
partnership, which is controlled directly or indirectly by a board
member/executive and/or a person mentioned in 1)-3), or to which a board
member/executive and/or a person mentioned in 1)-3) has managerial
responsibilities or economic interests substantially equivalent to the legal
person.
What is trading/transaction?
Trading is any kind of transaction, including shares purchased or otherwise
acquired, shares sold or otherwise disposed, gifts, mortgages and grants and
exercise of options, but not heritage.
Financial instrument includes shares listed on the NASDAQOMX Copenhagen and
London Stock Exchange as well as ADRs listed on New York Stock Exchange, except
for ADRs held in 401(k) retirement plan by US-based employees. The ID code is
the code (ISIN DK006010261) of the Novo Nordisk share on the NASDAQ OMX
Copenhagen, the code (NVOB) on London Stock Exchange or the code (NVO) on New
York Stock Exchange.
The volume of transaction is the number of shares (of DKK 1 nominal value) or
other financial instruments traded. The transaction value is the number of
shares traded multiplied by the transaction price. The exchange rate of the
Danish Central Bank (Nationalbanken) on the date of transaction is used for
calculating the transaction value in DKK in case of shares traded on London
Stock Exchange and ADRs listed on New York Stock Exchange.
Novo Nordisk is a healthcare company and a world leader in diabetes care. In
addition, Novo Nordisk has a leading position within areas such as haemostasis
management, growth hormone therapy and hormone replacement therapy. Novo Nordisk
manufactures and markets pharmaceutical products and services that make a
significant difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs over 29,300 employees in 76
countries, and markets its products in 179 countries. Novo Nordisk's B shares
are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed
on the New York Stock Exchange under the symbol 'NVO'. For more information,
visit novonordisk.com.
For further information please contact:
Media: Investors:
Outside North America: Outside North America:
Elin K Hansen Klaus Bülow Davidsen
Tel: (+45) 4442 3450 Tel: (+45) 4442 3176
ekh@novonordisk.com klda@novonordisk.com
<mailto:ekh@novonordisk.com> <mailto:klda@novonordisk.com>
Kasper Roseeuw Poulsen
Tel: (+45) 4442 4471
krop@novonordisk.com
<mailto:krop@novonordisk.com>
In North America: In North America
Sean Clements Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com hrmm@novonordisk.com
<mailto:lrmo@novonordisk.com> <mailto:hrmm@novonordisk.com>
Company Announcement no 5 / 2010
[HUG#1380318]
Company Announcement no 5 2010: http://hugin.info/2013/R/1380318/339895.pdf
Novo-N.Dkk1'b' (LSE:NVOB)
Historical Stock Chart
From Apr 2024 to May 2024
Novo-N.Dkk1'b' (LSE:NVOB)
Historical Stock Chart
From May 2023 to May 2024
